Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
E3 ubiquitin-protein ligase TRAIP (TRAIP) is a protein-coding gene product characterized by an N-terminal RING finger domain, coiled-coil regions, and a leucine zipper. TRAIP is an E3 ubiquitin ligase that undergoes auto-ubiquitination and regulates protein degradation via the ubiquitin-proteasome system. It was originally identified as an interactor of tumor necrosis factor receptor-associated factors (TRAFs), especially TRAF1 and TRAF2, and has been described to negatively regulate TRAF2-mediated NF-κB signaling, influencing cell activation and apoptosis. TRAIP is predominantly localized to the nucleolus in interphase cells and is tightly regulated during the cell cycle, with highest expression in G2/M. It plays a critical role in mitosis, particularly as a regulator of the spindle assembly checkpoint and in the DNA damage response by facilitating the recruitment of DNA repair machinery (RAP80, BRCA1) to sites of damage. TRAIP is essential for cell proliferation and normal embryonic development, as knockout models result in embryonic lethality due to apoptosis and reduced cell division. Overexpression of TRAIP is reported in certain cancers, suggesting relevance in tumorigenesis.
Not applicable (no drugs identified). For hypothetical drug action: inhibition of TRAIP could impact cell cycle progression, DNA repair, and apoptosis signaling based on its biological functions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on E3 ubiquitin-protein ligase TRAIP (TRAIP).